BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27049724)

  • 1. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
    Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
    Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
    Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
    Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
    Feng H; Ge F; Du L; Zhang Z; Liu D
    J Cell Mol Med; 2019 Aug; 23(8):5282-5291. PubMed ID: 31199581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
    Li D; Li DQ; Liu D; Tang XJ
    Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
    Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
    Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
    Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
    Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
    RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.
    Ma Z; Qiu X; Wang D; Li Y; Zhang B; Yuan T; Wei J; Zhao B; Zhao X; Lou J; Jin Y; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Aug; 47(8):630-8. PubMed ID: 26124189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.
    Zhang C; Wang H; Liu X; Hu Y; Ding L; Zhang X; Sun Q; Li Y
    Oncogene; 2019 Mar; 38(11):1892-1904. PubMed ID: 30390072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.
    Chu K; Gao G; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
    Int J Oncol; 2016 Feb; 48(2):577-86. PubMed ID: 26648284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA
    Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
    Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
    Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
    Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.